Market Research Report
Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023
|Published by||IMARC Services Private Limited||Product code||354155|
|Published||Content info||82 Pages
Delivery time: 1-2 business days
|Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023|
|Published: April 29, 2017||Content info: 82 Pages||
Driven by rising cancer incidences, patent expiry of a number of blockbuster oncology drugs and the high cost of cancer treatment, the market for generic oncology drugs has been witnessing robust growth. Apart from their strong growth, these drugs also enjoy high product differentiation and entry barriers. As a result, competitive intensity in this segment is also relatively low. This has enabled manufacturer to enjoy higher pricing power and margins compared to commoditised generics.
IMARC's latest study "Generic Oncology Drug Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic Oncology drug manufacturing plant. Aspects such as market size, industry trends, manufacturers, land, construction, machinery, labour, investments, revenues, rate of return, margins, etc. have been thoroughly covered in this report.